Why the study?
No study comparing the novel Polarx cryoablation system with the standard Arctic Front cryoballoon was available in the literature.
Does the Polarx™ cryoablation system improve procedural efficacy and safety compared to the Arctic Front™ cryoballoon in patients with paroxysmal atrial fibrillation?
Does the Polarx™ cryoablation system improve procedural efficacy and safety compared to the Arctic Front™ cryoballoon in patients with paroxysmal atrial fibrillation?
The novel Polarx™ cryoablation system demonstrates similar efficacy and safety to the Arctic Front™ system for paroxysmal AF ablation, but with significantly shorter procedure and fluoroscopy times.
Answers are grounded in this paper and cite their sources.
May shorten procedure and fluoroscopy times in paroxysmal AF ablation; hypothesis-generating and requires randomized confirmation before practice change.
BACKGROUND: The novel Polarx™ cryoablation system is currently being studied for atrial fibrillation (AF) ablation. To the best of our knowledge, no study comparing the novel cryoablation system with the standard Arctic Front™ cryoballoon is available in today's literature. This study aims to compare Polarx™ and Arctic Front™ cryoballoon in terms of safety and efficacy. METHODS: From a total cohort of 202 patients who underwent pulmonary vein (PV) isolation for paroxysmal AF through cryoablation, a population of 30 patients who used Polarx™ were compared with 30 propensity-score matched patients who used Arctic Front™. RESULTS: Pulmonary vein occlusion and electrical isolation were achieved in all (100%) veins with a mean number of 1.09 ± 0.3 occlusion per vein using Polarx™ and 1.19 ± 0.5 occlusion per vein using Arctic Front™ (p = 0.6). Shorter procedure and fluoroscopy time were observed with Polarx™ group (60.5 ± 14.23 vs 73.43 ± 13.26 mins, p = 0.001; 12.83 ± 6.03 vs 17.23 ± 7.17 mins, p = 0.01, respectively). Lower cumulative freeze duration per vein was also observed with Polarx™ (203.38 ± 72.03 vs 224.9 ± 79.35 mins, p = 0.02). There was no significant difference in isolation time between the two groups (34.47 ± 21.23 vs 34.18 ± 26.79 secs, p = 0.9). CONCLUSIONS: The novel Polarx™ cryoablation system showed similar efficacy in vein occlusion and isolation and safety profile when compared to Arctic Front™ cryoablation system. Procedure time, fluoroscopy time, and cumulative freeze duration were significantly lower with Polarx™ cryoablation system.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: